Kenneth Sim's most recent trade in Bunge Ltd. was a trade of 15 Common Stock done at an average price of $116.8 . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 116.80 per share. | 03 Mar 2026 | 15 | 8,798 (0%) | 0% | 116.8 | 1,752 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 96.44 per share. | 01 Dec 2025 | 18 | 8,783 (0%) | 0% | 96.4 | 1,736 | Common Stock |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.78 per share. | 10 Nov 2025 | 29,502 | 639,407 (1%) | 0% | 17.8 | 524,546 | Common Stock |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2025 | 29,502 | 0 | - | - | Stock Option (right to buy) | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 82.43 per share. | 02 Sep 2025 | 21 | 8,765 (0%) | 0% | 82.4 | 1,731 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 77.86 per share. | 02 Jun 2025 | 22 | 8,744 (0%) | 0% | 77.9 | 1,713 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 2,510 | 8,722 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd | Kenneth M. Simril | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.65 per share. | 15 May 2025 | 502 | 6,212 (0%) | 0% | 79.6 | 39,984 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 71.83 per share. | 04 Mar 2025 | 18 | 6,714 (0%) | 0% | 71.8 | 1,293 | Common Stock |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 15 Feb 2025 | 699,896 | 6,132,802 (11%) | 1% | 0 | Common Stock | |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 15 Feb 2025 | 26,232 | 546,349 (1%) | 0% | 0 | Common Stock | |
| Bunge Ltd | M. Kenneth Simril | Director | Grant, award, or other acquisition of securities at price $ 88.60 per share. | 02 Dec 2024 | 15 | 6,696 (0%) | 0% | 88.6 | 1,329 | Common Stock |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.65 per share. | 18 Nov 2024 | 28,046 | 609,905 (1%) | 0% | 18.7 | 523,058 | Common Stock |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2024 | 28,046 | 0 | - | - | Stock option (right to buy) | |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 133,333 | 581,859 (1%) | 0% | 0 | Common Stock | |
| Astrana Health Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 66,667 | 448,526 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 100.92 per share. | 02 Sep 2024 | 13 | 6,681 (0%) | 0% | 100.9 | 1,312 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 107.33 per share. | 03 Jun 2024 | 12 | 6,668 (0%) | 0% | 107.3 | 1,288 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 1,947 | 6,656 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd | Kenneth M. Simril | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.06 per share. | 11 May 2024 | 302 | 4,709 (0%) | 0% | 105.1 | 31,728 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 93.69 per share. | 01 Mar 2024 | 16 | 5,011 (0%) | 0% | 93.7 | 1,499 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 351,859 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 381,859 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Sim Kenneth | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 30,000 | 321,859 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 114.92 per share. | 01 Sep 2023 | 12 | 4,982 (0%) | 0% | 114.9 | 1,379 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 92.13 per share. | 02 Jun 2023 | 15 | 4,970 (0%) | 0% | 92.1 | 1,382 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 2,229 | 4,955 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 96.42 per share. | 02 Mar 2023 | 12 | 2,726 (0%) | 0% | 96.4 | 1,157 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 08 Dec 2022 | 51,445 | 243,272 (0%) | 0% | 10 | 514,450 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 51,445 | 0 | - | - | Warrants to purchase Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. | 08 Dec 2022 | 48,587 | 291,859 (0%) | 0% | 11 | 534,457 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2022 | 48,587 | 0 | - | - | Warrants to purchase Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 984,042 | 10,191,660 (19%) | 1% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Other type of transaction at price $ 0.00 per share. | 02 Dec 2022 | 37,439 | 520,117 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 96.50 per share. | 02 Dec 2022 | 12 | 2,714 (0%) | 0% | 96.5 | 1,158 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 100.09 per share. | 02 Sep 2022 | 11 | 2,702 (0%) | 0% | 100.1 | 1,101 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 114.62 per share. | 02 Jun 2022 | 8 | 2,691 (0%) | 0% | 114.6 | 917 | Common Stock |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 1,842 | 2,683 (0%) | 0% | 0 | Common Stock | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 107.25 per share. | 02 Mar 2022 | 4 | 841 (0%) | 0% | 107.3 | 429 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 392,816 | 0 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 392,816 | 0 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Feb 2022 | 258,824 | 230,576 (0%) | 0% | 0 | Common Stock | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 19,227 | 104,180 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 19,227 | 0 | - | - | Performance RSUs | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.34 per share. | 19 Feb 2022 | 12,214 | 97,518 (0%) | 0% | 162.3 | 1,982,821 | Common Stock, $0.01 Par Value |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 8,546 | 84,953 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 8,546 | 0 | - | - | Performance RSUs | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 2,248 | 106,428 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 2,248 | 0 | - | - | Time RSUs | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,697 | 109,732 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,697 | 3,396 | - | - | Time RSUs | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,607 | 108,035 (0%) | 0% | 0 | Common Stock, $0.01 Par Value | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2022 | 1,607 | 1,607 | - | - | Time RSUs | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 6,940 | 6,940 | - | - | Performance RSUs | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 5,998 | 5,998 | - | - | Time RSUs | |
| Crown Castle | Kenneth J. Simon | EVP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 4,762 | 4,762 | - | - | Performance RSUs | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 85.80 per share. | 02 Dec 2021 | 5 | 837 (0%) | 0% | 85.8 | 429 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Nov 2021 | 230,688 | 397,724 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 65,242 | 191,827 (0%) | 0% | 0 | Common Stock | |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Nov 2021 | 29,502 | 29,502 | - | - | Stock Option (right to buy) | |
| Bunge Ltd | Kenneth M. Simril | Director | Grant, award, or other acquisition of securities at price $ 88.47 per share. | 25 Oct 2021 | 832 | 832 (0%) | 0% | 88.5 | 73,603 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 30 Mar 2021 | 31,756 | 859,101 (1%) | 0% | 10 | 317,560 | Common Stock |
| Apollo Medical Holdings Inc | Kenneth Sim | Director, Executive Chairman and Co-CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 31,756 | 0 | - | - | Warrant to Purchase Common Stock |